Inside Merck's $11B Prometheus battle

Today's Big News

May 2, 2023

BREAKING: GSK staffers kick off series of strikes in UK for the first time in drugmaker's history


Pfizer drops newly-acquired meds from Arena as part of midstage cleaning


Zimmer Biomet picks up 3D-printed orthopedic implant maker Ossis


Bristol Myers accuses AstraZeneca of infringing patent on cancer blockbuster Opdivo—again


Merck battled 2 other Big Pharmas to the end in pursuit of $11B Prometheus deal


FDA: The heart-checking smart toilet seat is a go

 

Featured

GSK staffers kick off series of strikes in UK for the 1st time in drugmaker's history

Workers at GSK’s Montrose facility in Scotland on Tuesday kicked off a series of strikes that will sequentially affect six of the company’s sites and last throughout May.
 

Top Stories

Pfizer kicks newly acquired meds out of Arena as part of midstage cleaning

Pfizer is axing a handful of midstage medicines, most of which stemmed from the company's acquisition of Arena Pharmaceuticals. Company executives also noted on its first-quarter earnings call that it remains on the M&A hunt even after acquiring Seagen for almost $50 billion.

Zimmer Biomet picks up 3D-printed orthopedic implant maker Ossis

Less than two years after they first teamed up to distribute 3D-printed implants throughout the Asia-Pacific region—and only a few months after they expanded that partnership even further across the globe—Zimmer Biomet and Ossis are taking their relationship to the next level.

Bristol Myers accuses AstraZeneca of infringing patent on cancer blockbuster Opdivo—again

In a new lawsuit between oncology giants, Bristol Myers Squibb claims AstraZeneca willfully infringed a key Opdivo patent.

Merck battled 2 other Big Pharmas to the end in pursuit of $11B Prometheus deal

After releasing positive data for a bowel disease candidate in December, Prometheus headed into the J.P. Morgan healthcare conference in January as the talk of San Francisco.

FDA: The heart-checking smart toilet seat is a go

Casana—a startup describing itself as “the industry leader in monitoring heart health through smart toilets”—has received a green light for its Heart Seat to log users’ pulse rate and blood oxygen saturation.

Merck entitled to $1.4B in cyberattack case after court rejects insurers' 'warlike action' claim

A New Jersey appellate court ruled that a group of insurers can’t use war as an argument to deny Merck coverage from the notorious NotPetya cyberattack in 2017.

Incyte whittles down pipeline, scrapping 6 R&D programs

Incyte is whittling down its R&D pipeline, scrapping six discovery programs—one in a rare form of anemia and five in various cancers—to focus on eight remaining programs.

J&J refuels CAR-T ambitions with $245M upfront to Cellular Biomedicine for pair of therapies

Johnson & Johnson may have gone quiet on getting further CAR-Ts into the clinic beyond the success of its Legend-partnered Carvykti, but that’s about to change.

Masimo delivers new audio-video baby monitor system with health-tracking boot

It’s a… sensor! Masimo welcomed the newest addition to its product family this week as it unveiled the Stork health-monitoring system for babies up to 18 months old.

With FDA nod for Lumryz, Avadel is set to Jazz up the narcolepsy market

Avadel Pharmaceuticals’ Lumryz has won approval from the FDA and becomes the first nightly, single-dose oral treatment for narcolepsy. The endorsement is a major threat to the market domination of Jazz Pharmaceuticals’ Xyrem, which requires two doses per night.

Dual CRISPR therapy plus long-acting ART eliminates HIV in mice

The scientists who used CRISPR to eliminate HIV in mice have done it again, this time with a three-pronged approach that nearly doubled their success rate.
 
Fierce podcasts

Don't miss an episode

'The Top Line': A special series on Narcan, the life-saving nasal spray

This week on "The Top Line," we're launching a mini-series on Narcan the nasal spray. It is the first naloxone product to be approved for use without a prescription.
 

Resources

eBook

Decentralized Clinical Trials: The Complete Guide for 2023

Discover a game-changing approach to clinical research with Hybrid and Decentralized Clinical Trials (DCTs). Learn about the benefits, challenges, and key elements for success.
Research

How Lilly’s Legal and Library Services Empower Teams Across the Drug Development Pipeline

What role do the Library and Legal teams play in the drug development pipeline at Lilly? An import one – find out how.
Whitepaper

Medical Affairs Metamorphosis VI: The Changing Face of Stakeholder Engagement

This paper focuses on stakeholder engagement and how Medical Affairs teams’ responsibilities, goals, tools, and techniques are changing.
Research

Maximizing Clinical Trial Success

Strategies for Optimal Site Selection and Feasibility Research in Novel Therapies and Geographies
Whitepaper

eConsent: Flexible Consent Through Enabling Technologies

How can eConsent provide a more flexible approach to informed consent?
Whitepaper

Plan for scalable process liquid and buffer preparation

Preparation of critical process liquids and buffer components shifts resources away from core activities and can be filled with inefficiencies and risks that can increase time and costs across your workflow. Learn about the framework to help reduce your total costs beyond capital and operational expenditures and set a solid foundation for successful scale-up of buffer preparation.
Whitepaper

Running Decentralized Trials at Scale

Explore how clinical supply can be scaled up as decentralized programs progress, and how technological solutions can accelerate trial deployment.
Whitepaper

Designing an Optimal APAC Clinical Supply Chain

Discover key considerations that every trial sponsor should know when navigating the complex clinical supply distribution landscape across Asia-Pacific.
Whitepaper

Key Clinical Supply Issues Sponsors Should Consider with their CRO

As sponsors increasingly look to CROs to support their clinical studies, making and addressing certain clinical supply considerations at the outset of the relationship can reduce the risk of potentially unforeseen impact to budget and time later. Discover key issues sponsors should consider to help their CRO or partner of choice better understand their clinical supply needs.

Whitepaper

Specialized Expertise for Management of Clinical Supply Budgets

For sponsors, cost is a key concern when it comes to managing the supply of their clinical trials. A financial project analyst (FPA) is a specialized expert who can help control clinical supply costs and keep the project within budget. Explore the critical role that a Financial Project Analyst plays in clinical trial supply and budget management.
Whitepaper

Clinical Supply Solutions for the Asia-Pacific Region

Learn how Catalent’s extensive network across APAC can meet a wide range of clinical supply needs for sponsors conducting trials within the region.
Whitepaper

Roles and Responsibilities of Specialized Clinical Supply Experts

How can specialized expertise help you optimize your clinical supply chain? Learn about the roles and responsibilities of unique experts such as clinical supply management, project management, and financial project analysis.
Whitepaper

Questions You Need to Ask Your CRO About Clinical Supply

Planning on using a CRO to support your next clinical study? This infographic outlines critical areas to address at the start of the relationship in order to ensure that budget and timelines keep on track for the duration of the trial.
Whitepaper

Supply Services to Support Clinical Trials in Japan & Beyond

Explore Catalent’s newest clinical supply facility in Japan, including the comprehensive services & solutions it offers to help support trials both in-country & around the world.
 

Industry Events

 

Upcoming Fierce Events

1-3
May
May 1-3, 2023 | Jersey City, NJ
12-14
Jun
San Diego, CA
13
Jun
Free Virtual Event
20-22
Jun
Free Virtual Event
22
Jun
Free Virtual Event

View all events